Get the Stockscreener App
99.66
1.83%
-1.86
After Hours:
99.66
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $99.66, with a volume of 927.41K.
It is down -1.83% in the last 24 hours and up +0.36% over the past month.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
See More
Previous Close:
$101.52
Open:
$102.34
24h Volume:
927.41K
Relative Volume:
0.73
Market Cap:
$11.12B
Revenue:
$2.90B
Net Income/Loss:
$239.11M
P/E Ratio:
47.24
EPS:
2.1097
Net Cash Flow:
$492.62M
1W Performance:
+1.31%
1M Performance:
+0.36%
6M Performance:
-0.83%
1Y Performance:
+4.14%
1-Day Range:
$98.42
$103.60
1-Week Range:
$98.42
$106.20
52-Week Range:
$81.22
$118.30
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
99.66 | 11.12B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
469.34 | 174.42B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
180.10 | 127.47B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.88 | 44.24B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
129.84 | 36.67B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
355.53 | 34.91B | 3.77B | 449.25M | 240.68M | 7.8556 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Goldman | Neutral |
| Oct-16-25 | Initiated | Guggenheim | Neutral |
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
RVTY Technical Analysis & Stock Price Forecast - Intellectia AI
Revvity Inc. Stock (US76155R1086): valuation focus after quiet trading - AD HOC NEWS
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
Revvity Opera Phenix Plus: high-content screening system in focus for US labs - AD HOC NEWS
Revvity Inc. Stock (US76155R1086): neutral day with the shares in focus - AD HOC NEWS
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
What to expect from Revvity's next quarterly earnings report - MSN
Revvity Inc (RVTY) Shares Surge 3.8% -- What GF Score of 78 Tells Investors - GuruFocus
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity stock (US76155R1086): investors eye diagnostics and life science tools story - AD HOC NEWS
Revvity Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Revvity (RVTY) Valuation Check After China Immunodiagnostics Exit Plan And Solid First Quarter Results - Yahoo Finance
Revvity stock edges higher above $99 as technical momentum holds after image of the month post - Traders Union
Revvity, Inc. (RVTY) Stock Analysis: A Compelling 15.53% Upside in the Healthcare Diagnostics Sector - DirectorsTalk Interviews
Dilution adjustment of Revvity, Inc. – XETR:PKN - TradingView
(RVTY) Volatility Zones as Tactical Triggers - Stock Traders Daily
Revvity, Inc. Trade Ideas — XETR:PKN - TradingView
Revvity, Inc. Cash Flow – XETR:PKN - TradingView
Revvity, Inc. Balance Sheet – XETR:PKN - TradingView
Stifel cuts Revvity stock price target on softer valuation - Investing.com
Revvity gains on diagnostics strength, faces China headwinds - MSN
Revvity Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Why is Revvity (RVTY) up 2% since last earnings report? - MSN
Why Is Revvity (RVTY) Up 2% Since Last Earnings Report? - Yahoo Finance
Wolfe Research Initiates Revvity(RVTY.US) With Hold Rating - Moomoo
RVTY Assumed by Wolfe Research -- Rating Set to Peer Perform - GuruFocus
Revvity Inc (RVTY) Stock Down 3.9% -- Now Undervalued? GF Score: 74/100 - GuruFocus
Wolfe Research initiates Revvity stock coverage with Peerperform - Investing.com UK
Wolfe Research initiates Revvity stock coverage with Peerperform By Investing.com - Investing.com Nigeria
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why Is S&P 500 Attention on Revvity After Earnings Miss? - Kalkine Media
Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers - Yahoo Finance
Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Innovator With 8.7% Potential Upside - DirectorsTalk Interviews
RVTY unveils Signals BioDesign for faster molecular cloning & R&D data - MSN
Revvity Inc. stock (US76155R1086): NYSE price holds near 100 USD as technical levels draw focus - AD HOC NEWS
Revvity Inc. stock (US76155R1086): insider activity and recent trading in focus - AD HOC NEWS
Revvity (RVTY) Q1 earnings and revenues top estimates - MSN
A Look at Revvity Inc (RVTY) After 4.6% Gain -- GF Value $120.39 vs Price $101.22 - GuruFocus
Revvity stock (US76155R1086): New share repurchase plan sets tone after recent earnings - AD HOC NEWS
Price-Driven Insight from (RVTY) for Rule-Based Strategy - Stock Traders Daily
RVTY Stock Price and Chart — NYSE:RVTY - TradingView
Revvity stock (US76155R1086): life-science player after recent earnings in focus - AD HOC NEWS
Revvity, Inc. (RVTY) Stock Analysis: A Blend of Healthcare Innovation and Notable Growth Potential - DirectorsTalk Interviews
Revvity stock: Analyst estimates & ratings - MSN
Revvity stock (US76155R1086): cancer test launch and steady demand keep diagnostics group in focus - AD HOC NEWS
Revvity declares $0.07 dividend - MSN
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.38%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):